Articles
A little DED advice: Prescribe to variety
With only two FDA-approved drugs for dry eye disease, it’s good to have more than a Plan B.
By Karen Blum, Contributing
A NOD to a painful, puzzling diagnosis
Nonobvious dry eye disease may have a neuropathic basis, so look for symptoms; signs might prove elusive.
By Richard A. Adler, MD
DED surveys: reality v. perception
Physicians say they talk to patients about the dangers lurking in cosmetics; patients say otherwise.
By Laura M. Periman, MD
Does symptom-free mean dry eye-free?
No: nerve damage, systemic conditions and environmental factors can contribute to asymptomatic dry eye.
By Wendy Lyons Sunshine, Contributing
Giving birth to a dry eye clinic
DED mavens — two established, one en route — provide pearls, expose pitfalls and show how it’s done.
By Patti Barkey, COE
Heading for the exit?
Are ophthalmologists retiring due to the heavy hand of the government?
By Robert Calandra, Contributing
IN SO MANY WORDS
Alimera’s Dan Myers
Quick Hits
By By ReN
SPOTLIGHT ON TECHNOLOGY & TECHNIQUE
A choice instrument for dry eye clinics
By Robert Stoneback, associate editor
Viewpoint
This branch needs pruning
When beauty doesn’t blink
We look at exacerbators of ocular surface disease that lurk on product labels in cosmetics bags.
By Laura M. Periman, MD
CATARACT SURGERY: To Drop or Not to Drop?
Experts discuss new options for drug delivery in the ASC
By Desiree Ifft, Contributing
Changing Dry Eye Treatment
Old standbys still help, but the latest dry eye therapies are life-changing
Going Live
Practical tips to ensure your ASC is ready for a new subspecialist’s first surgery day
By Virginia Pickles, Contributing
Eight Reasons to Focus on OSD in Women
When health needs are unmet despite the prevalence of disease, it’s time to work harder
IV-free Cataract Surgery
By JOHN BERDAHL, MD
New Arrival: Tecnis Symfony IOL
By MARIA SCOTT, MD
One Step, One Punch, One Fight
On boxing and the ophthalmic ASC
The Virtue of Withholding Judgment
By KENT JACKSON, PHD, EXECUTIVE
Three Beneficial Diagnostic Options
Tear osmolarity, MMP-9 testing, and meibography deliver the big picture
Under the Radar Screen: ASC Reimbursement Issues
By RIVA LEE ASBELL